Page last updated: 2024-10-25

clofibrate and Lipidoses

clofibrate has been researched along with Lipidoses in 3 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.

Research Excerpts

ExcerptRelevanceReference
"Phospholipidosis is an adverse effect caused by numerous cationic amphiphilic drugs and can affect many cell types."1.36Predicting phospholipidosis using machine learning. ( Glen, RC; Lowe, R; Mitchell, JB, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lowe, R1
Glen, RC1
Mitchell, JB1
BEST, MM1
DUNCAN, CH1
Metelitsa, VI1
Matova, EE1
Aptekar', SG1

Other Studies

3 other studies available for clofibrate and Lipidoses

ArticleYear
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Bio

2010
HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    The Journal of laboratory and clinical medicine, 1964, Volume: 64

    Topics: Adrenalectomy; Androsterone; Anticholesteremic Agents; Butyrates; Castration; Cholesterol; Clofibrat

1964
[Experimental lipoidosis of the aorta in rabbits with endogenous hypercholesteremia and without anisotropic adiposis of the liver].
    Arkhiv patologii, 1971, Volume: 33, Issue:5

    Topics: Adipose Tissue; Aminocaproates; Animals; Aorta; Cholesterol; Clofibrate; Dietary Fats; Disease Model

1971